These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26287645)

  • 1. Soluble ST2 and myocardial fibrosis in 3T cardiac magnetic resonance.
    Quick S; Waessnig NK; Kandler N; Poitz DM; Schoen S; Ibrahim K; Strasser RH; Speiser U
    Scand Cardiovasc J; 2015; 49(6):361-6. PubMed ID: 26287645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased soluble ST2 predicts long-term mortality in patients with stable coronary artery disease: results from the Ludwigshafen risk and cardiovascular health study.
    Dieplinger B; Egger M; Haltmayer M; Kleber ME; Scharnagl H; Silbernagel G; de Boer RA; Maerz W; Mueller T
    Clin Chem; 2014 Mar; 60(3):530-40. PubMed ID: 24401186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic utility of ST2 in patients with acute dyspnea and preserved left ventricular ejection fraction.
    Shah KB; Kop WJ; Christenson RH; Diercks DB; Henderson S; Hanson K; Li SY; deFilippi CR
    Clin Chem; 2011 Jun; 57(6):874-82. PubMed ID: 21515743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble ST2 Receptor: Biomarker of Left Ventricular Impairment and Functional Status in Patients with Inflammatory Cardiomyopathy.
    Obradovic DM; Büttner P; Rommel KP; Blazek S; Loncar G; von Haehling S; von Roeder M; Lücke C; Gutberlet M; Thiele H; Lurz P; Besler C
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction.
    Weir RA; Miller AM; Murphy GE; Clements S; Steedman T; Connell JM; McInnes IB; Dargie HJ; McMurray JJ
    J Am Coll Cardiol; 2010 Jan; 55(3):243-50. PubMed ID: 20117403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting value of serum soluble ST2 and interleukin-33 for risk stratification and prognosis in patients with acute myocardial infarction.
    Zhang K; Zhang XC; Mi YH; Liu J
    Chin Med J (Engl); 2013; 126(19):3628-31. PubMed ID: 24112154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble ST2 protein in the short-term prognosis after hospitalisation in chronic systolic heart failure.
    Wojtczak-Soska K; Sakowicz A; Pietrucha T; Lelonek M
    Kardiol Pol; 2014; 72(8):725-34. PubMed ID: 24846354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ST2 may not be a useful predictor for incident cardiovascular events, heart failure and mortality.
    Hughes MF; Appelbaum S; Havulinna AS; Jagodzinski A; Zeller T; Kee F; Blankenberg S; Salomaa V;
    Heart; 2014 Nov; 100(21):1715-21. PubMed ID: 25080471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ST2 pathogenetic profile in ambulatory heart failure patients.
    Bayes-Genis A; Januzzi JL; Gaggin HK; de Antonio M; Motiwala SR; Zamora E; Galán A; Domingo M; Urrutia A; Lupón J
    J Card Fail; 2015 Apr; 21(4):355-61. PubMed ID: 25451702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1 receptor-related protein ST2 and mitral valve repair outcome in patients with chronic degenerative mitral regurgitation.
    Galeone A; Lessana A; Mascolo E; Di Serio F; Marraudino N; Laborde F; Paparella D
    Thorac Cardiovasc Surg; 2014 Feb; 62(1):47-51. PubMed ID: 24065602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating biomarkers of hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy assessed by cardiac magnetic resonance.
    Gawor M; Śpiewak M; Kubik A; Wróbel A; Lutyńska A; Marczak M; Grzybowski J
    Biomarkers; 2018 Nov; 23(7):676-682. PubMed ID: 29737871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble ST2 is a marker for acute cardiac allograft rejection.
    Pascual-Figal DA; Garrido IP; Blanco R; Minguela A; Lax A; Ordoñez-Llanos J; Bayes-Genis A; Valdés M; Moore SA; Januzzi JL
    Ann Thorac Surg; 2011 Dec; 92(6):2118-24. PubMed ID: 22035779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic Resonance Imaging-Detected Myocardial Inflammation and Fibrosis in Rheumatoid Arthritis: Associations With Disease Characteristics and N-Terminal Pro-Brain Natriuretic Peptide Levels.
    Kobayashi H; Kobayashi Y; Yokoe I; Akashi Y; Takei M; Giles JT
    Arthritis Care Res (Hoboken); 2017 Sep; 69(9):1304-1311. PubMed ID: 27813364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology.
    Broch K; Ueland T; Nymo SH; Kjekshus J; Hulthe J; Muntendam P; McMurray JJ; Wikstrand J; Cleland JG; Aukrust P; Gullestad L
    Eur J Heart Fail; 2012 Mar; 14(3):268-77. PubMed ID: 22302661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NT-proBNP levels in the evaluation of right ventricular dysfunction in patients with coronary artery disease and abnormal left ventricular wall motion: a magnetic resonance imaging study.
    Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Udompunturak S
    Coron Artery Dis; 2008 Nov; 19(7):481-7. PubMed ID: 18923244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining potential to benefit from implantable cardioverter defibrillator therapy: the role of biomarkers.
    Scott PA; Townsend PA; Ng LL; Zeb M; Harris S; Roderick PJ; Curzen NP; Morgan JM
    Europace; 2011 Oct; 13(10):1419-27. PubMed ID: 21784745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation Between NT-pro BNP levels and left ventricular wall stress, sphericity index and extent of myocardial damage: a magnetic resonance imaging study.
    Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Thanapiboonpol P; Nakyen S; Udompunturak S
    J Card Fail; 2008 Oct; 14(8):687-94. PubMed ID: 18926441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of cardiac magnetic resonance-detected myocardial abnormalities with disease characteristics and brain natriuretic peptide levels in systemic sclerosis without cardiac symptoms.
    Sugiyama K; Kobayashi H; Kobayashi Y; Yokoe I; Takei M; Kitamura N
    Int J Rheum Dis; 2019 Jun; 22(6):1016-1022. PubMed ID: 30924296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of myocardial fibrosis on left ventricular torsion and twist in patients with non-ischemic dilated cardiomyopathy.
    Karaahmet T; Gürel E; Tigen K; Güler A; Dündar C; Fotbolcu H; Basaran Y
    Cardiol J; 2013; 20(3):276-86. PubMed ID: 23788302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure.
    Pascual-Figal DA; Manzano-Fernández S; Boronat M; Casas T; Garrido IP; Bonaque JC; Pastor-Perez F; Valdés M; Januzzi JL
    Eur J Heart Fail; 2011 Jul; 13(7):718-25. PubMed ID: 21551163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.